Company Profile
Bluejay Diagnostics Stock Price, News & Analysis
- Ticker:
- BJDX
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
1.15 USD (-7.26%)
Close
Last updated: August 6, 2026
4.49M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, BJDX closed down 7.26% at $1.15. No new same-company headline was identified in the current news window.
Company overview
Business overview
Bluejay Diagnostics is a medical diagnostics company focused on rapid testing and blood-based diagnostic tools. Its business is centered on bringing point-of-care information to clinical settings rather than developing therapeutics.
Geographic Base and Sector Classification
Bluejay Diagnostics is headquartered in the United States and listed on NASDAQ. It sits in diagnostics and medical devices rather than biotechnology.
Business Model Characteristics
The company depends on product validation, adoption, and reimbursement or clinical workflow integration. Investors typically watch test commercialization and operating execution.
Position Within the Biotechnology Landscape
Bluejay sits in the diagnostics infrastructure layer of healthcare. It is not biotech proper, but it matters because better testing can affect how care is delivered.
Future catalysts
Bluejay Diagnostics’ catalysts are point-of-care diagnostic adoption and any operating update that clarifies the commercialization path. The market cares about whether the test can gain real workflow usage.
Recent news
- 01
- 02
- 03
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Source: Bluejay Diagnostics
- 04
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
Source: Bluejay Diagnostics
- 05
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
Source: Bluejay Diagnostics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bluejay Diagnostics (BJDX)?
Bluejay Diagnostics (BJDX) most recently closed at 1.15 USD, a -7.26% move versus the previous session.
What is the market cap of Bluejay Diagnostics (BJDX)?
Bluejay Diagnostics currently has a market capitalization of 4.49M USD on BioPharmSignal.
What does Bluejay Diagnostics do?
Bluejay Diagnostics is a medical diagnostics company focused on rapid testing and blood-based diagnostic tools. Its business is centered on bringing point-of-care information to clinical settings rather than developing therapeutics.
On which exchange is BJDX stock listed?
Bluejay Diagnostics (BJDX) is associated with NASDAQ, United States, MedTech.
What is Bluejay?
Bluejay Diagnostics’ catalysts are point-of-care diagnostic adoption and any operating update that clarifies the commercialization path.
Which conditions is Bluejay Diagnostics targeting with Bluejay?
Bluejay Diagnostics’ catalysts are point-of-care diagnostic adoption and any operating update that clarifies the commercialization path.
How does Bluejay Diagnostics describe recent progress with Bluejay?
Bluejay Diagnostics’ catalysts are point-of-care diagnostic adoption and any operating update that clarifies the commercialization path.
What is Diagnostics?
Bluejay Diagnostics is a medical diagnostics company focused on rapid testing and blood-based diagnostic tools.